Published in Genetics on July 01, 1987
Stoichiometric flux balance models quantitatively predict growth and metabolic by-product secretion in wild-type Escherichia coli W3110. Appl Environ Microbiol (1994) 6.26
Evolution of microbial diversity during prolonged starvation. Proc Natl Acad Sci U S A (1999) 3.18
Molecular characterization of clonal interference during adaptive evolution in asexual populations of Saccharomyces cerevisiae. Nat Genet (2008) 2.98
Parallel adaptive evolution cultures of Escherichia coli lead to convergent growth phenotypes with different gene expression states. Genome Res (2005) 2.91
Shifts in growth strategies reflect tradeoffs in cellular economics. Mol Syst Biol (2009) 2.26
Parallel evolutionary dynamics of adaptive diversification in Escherichia coli. PLoS Biol (2013) 2.19
Mutations enhancing amino acid catabolism confer a growth advantage in stationary phase. J Bacteriol (1999) 2.11
The Beagle in a bottle. Nature (2009) 2.11
Profiles of adaptation in two similar viruses. Genetics (2001) 1.99
Microbial laboratory evolution in the era of genome-scale science. Mol Syst Biol (2011) 1.78
On genetic map functions. Genetics (1996) 1.64
Adaptive molecular evolution for 13,000 phage generations: a possible arms race. Genetics (2005) 1.59
Why does Escherichia coli have two primary pathways for synthesis of glutamate? J Bacteriol (1994) 1.47
Dynamics in the mixed microbial concourse. Genes Dev (2010) 1.45
Evolutionary engineering of Saccharomyces cerevisiae for anaerobic growth on xylose. Appl Environ Microbiol (2003) 1.45
The ecology of nasal colonization of Streptococcus pneumoniae, Haemophilus influenzae and Staphylococcus aureus: the role of competition and interactions with host's immune response. BMC Microbiol (2010) 1.44
Experimental analysis of molecular events during mutational periodic selections in bacterial evolution. Genetics (2000) 1.37
Long-term experimental evolution in Escherichia coli. XIII. Phylogenetic history of a balanced polymorphism. J Mol Evol (2005) 1.37
Unparallel diversification in bacterial microcosms. Proc Biol Sci (2005) 1.31
New insights into bacterial adaptation through in vivo and in silico experimental evolution. Nat Rev Microbiol (2012) 1.28
Unraveling microbial interactions in food fermentations: from classical to genomics approaches. Appl Environ Microbiol (2008) 1.25
Pathway choice in glutamate synthesis in Escherichia coli. J Bacteriol (1998) 1.23
Parallel and divergent genotypic evolution in experimental populations of Ralstonia sp. J Bacteriol (1998) 1.20
E Unibus Plurum: genomic analysis of an experimentally evolved polymorphism in Escherichia coli. PLoS Genet (2009) 1.18
Speed versus efficiency in microbial growth and the role of parallel pathways. J Bacteriol (2002) 1.17
Enrichment and elimination of mutY mutators in Escherichia coli populations. Genetics (2002) 1.16
Mutational adaptation of Escherichia coli to glucose limitation involves distinct evolutionary pathways in aerobic and oxygen-limited environments. Genetics (1999) 1.16
Spatial structure leads to ecological breakdown and loss of diversity. Proc Biol Sci (2009) 1.15
The influence of cellular physiology on the initiation of mutational pathways in Escherichia coli populations. Proc Biol Sci (2003) 1.11
The repeatability of adaptive radiation during long-term experimental evolution of Escherichia coli in a multiple nutrient environment. PLoS One (2010) 1.11
Selection intensity for codon bias and the effective population size of Escherichia coli. Genetics (1996) 1.10
Niche occupation limits adaptive radiation in experimental microcosms. PLoS One (2007) 1.10
Community flux balance analysis for microbial consortia at balanced growth. PLoS One (2013) 1.08
Divergence and redundancy of transport and metabolic rate-yield strategies in a single Escherichia coli population. J Bacteriol (2006) 1.06
Interactions in the microbiome: communities of organisms and communities of genes. FEMS Microbiol Rev (2013) 1.05
Evolution of specialists in an experimental microcosm. Genetics (2004) 1.05
Design and use of multiplexed chemostat arrays. J Vis Exp (2013) 1.04
Perceiving molecular evolution processes in Escherichia coli by comprehensive metabolite and gene expression profiling. Genome Biol (2008) 1.03
FREQ-Seq: a rapid, cost-effective, sequencing-based method to determine allele frequencies directly from mixed populations. PLoS One (2012) 1.01
Adaptation of Salmonella typhimurium mutants containing uncoupled enzyme IIGlc to glucose-limited conditions. J Bacteriol (1990) 0.98
The evolution of contact-dependent inhibition in non-growing populations of Escherichia coli. Proc Biol Sci (2008) 0.97
Protein carbon content evolves in response to carbon availability and may influence the fate of duplicated genes. Proc Biol Sci (2007) 0.95
Founder niche constrains evolutionary adaptive radiation. Proc Natl Acad Sci U S A (2013) 0.94
The spectrum of adaptive mutations in experimental evolution. Genomics (2014) 0.94
The enduring utility of continuous culturing in experimental evolution. Genomics (2014) 0.93
Evolution of resource cycling in ecosystems and individuals. BMC Evol Biol (2009) 0.91
Stock culture heterogeneity rather than new mutational variation complicates short-term cell physiology studies of Escherichia coli K-12 MG1655 in continuous culture. Microbiology (2011) 0.89
Synthetic ecology: a model system for cooperation. Proc Natl Acad Sci U S A (2007) 0.89
Resource availability and competition shape the evolution of survival and growth ability in a bacterial community. PLoS One (2013) 0.88
Adaptation of model genetically engineered microorganisms to lake water: growth rate enhancements and plasmid loss. Appl Environ Microbiol (1992) 0.87
Differences in codon bias cannot explain differences in translational power among microbes. BMC Bioinformatics (2005) 0.86
Mutations in global regulators lead to metabolic selection during adaptation to complex environments. PLoS Genet (2014) 0.85
Ecological perspectives on synthetic biology: insights from microbial population biology. Front Microbiol (2015) 0.85
Genetic changes accompanying increased fitness in evolving populations of Escherichia coli. Genetics (1992) 0.85
Microbial resource utilization traits and trade-offs: implications for community structure, functioning, and biogeochemical impacts at present and in the future. Front Microbiol (2015) 0.84
Intra-tumor heterogeneity: lessons from microbial evolution and clinical implications. Genome Med (2013) 0.84
Survival response and rearrangement of plasmid DNA of Lactococcus lactis during long-term starvation. Appl Environ Microbiol (2001) 0.84
Pervasive Selection for Cooperative Cross-Feeding in Bacterial Communities. PLoS Comput Biol (2016) 0.84
Crowded growth leads to the spontaneous evolution of semistable coexistence in laboratory yeast populations. Proc Natl Acad Sci U S A (2015) 0.84
Laboratory-dependent bacterial ecology: a cautionary tale. Appl Environ Microbiol (2006) 0.83
SIZE DOESN'T MATTER: MICROBIAL SELECTION EXPERIMENTS ADDRESS ECOLOGICAL PHENOMENA. Ecology (2003) 0.83
Ex uno plures: clonal reinforcement drives evolution of a simple microbial community. PLoS Genet (2014) 0.83
Genomic investigations of evolutionary dynamics and epistasis in microbial evolution experiments. Curr Opin Genet Dev (2015) 0.82
Quantifying the effects of the division of labor in metabolic pathways. J Theor Biol (2014) 0.78
Emergence of microbial diversity due to cross-feeding interactions in a spatial model of gut microbial metabolism. BMC Syst Biol (2017) 0.78
Dynamics of Simple Food Webs. Bull Math Biol (2015) 0.76
Stability of Cross-Feeding Polymorphisms in Microbial Communities. PLoS Comput Biol (2016) 0.76
Beware batch culture: Seasonality and niche construction predicted to favor bacterial adaptive diversification. PLoS Comput Biol (2017) 0.75
Evolutionary pressures on microbial metabolic strategies in the chemostat. Sci Rep (2016) 0.75
Evolutionary rescue and the coexistence of generalist and specialist competitors: an experimental test. Proc Biol Sci (2015) 0.75
Replaying Evolution to Test the Cause of Extinction of One Ecotype in an Experimentally Evolved Population. PLoS One (2015) 0.75
Evolution of coexistence in a crowded microplate well. Proc Natl Acad Sci U S A (2015) 0.75
The clonal evolution of tumor cell populations. Science (1976) 24.39
Experiments with the Chemostat on spontaneous mutations of bacteria. Proc Natl Acad Sci U S A (1950) 18.19
The generation of a ColE1-Apr cloning vehicle which allows detection of inserted DNA. Mol Gen Genet (1975) 8.80
Phosphoenolpyruvate:carbohydrate phosphotransferase system of bacteria. Microbiol Rev (1985) 5.90
Selective neutrality of 6PGD allozymes in E. coli and the effects of genetic background. Genetics (1980) 5.27
The population genetics of Escherichia coli. Annu Rev Genet (1984) 4.29
Evolution of tumours and the impact of molecular oncology. Nature (1985) 4.24
Direct selection of L-arabinose negative mutants of Escherichia coli strain B@rl. Genetics (1962) 4.05
THE GLUCOSE PERMEASE SYSTEM IN BACTERIA. Biochim Biophys Acta (1964) 3.78
Frequency of fixation of adaptive mutations is higher in evolving diploid than haploid yeast populations. Nature (1983) 3.03
Frequency-Dependent Selection for Plasmid-Containing Cells of ESCHERICHIA COLI. Genetics (1979) 2.07
The maintenance of Plasmid-containing organisms in populations of Escherichia coli. J Gen Microbiol (1981) 1.85
Metabolic regulation in glucose-limited chemostat cultures of Escherichia coli. J Bacteriol (1970) 1.75
The role of energy-spilling reactions in the growth of Klebsiella aerogenes NCTC 418 in aerobic chemostat culture. Arch Microbiol (1976) 1.54
Stimulation of glycolysis and amino acid uptake in NRK-49F cells by transforming growth factor beta and epidermal growth factor. Proc Natl Acad Sci U S A (1985) 1.51
Physiological characterization of adaptive clones in evolving populations of the yeast, Saccharomyces cerevisiae. Genetics (1985) 1.28
Structure of evolving populations of Saccharomyces cerevisiae: adaptive changes are frequently associated with sequence alterations involving mobile elements belonging to the Ty family. Proc Natl Acad Sci U S A (1986) 1.26
The control by respiration of the uptake of alpha-methyl glucoside in Escherichia coli K12. Arch Microbiol (1975) 1.18
Tumors; a mixed bag of cells. Science (1982) 1.00
Transport of alpha-methyl glucoside in mutants of Escherichia coli K12 deficient in Ca2+, Mg2+-activated adenosine triphosphatase. Biochem Biophys Res Commun (1975) 0.97
Glucose transport in Salmonella typhimurium and Escherichia coli. Eur J Biochem (1982) 0.92
Transport of alpha-methyl glucoside in a cytochrome-deficient mutant of Escherichia coli K-12. FEBS Lett (1976) 0.90
Construction of biologically functional bacterial plasmids in vitro. Proc Natl Acad Sci U S A (1973) 25.61
Analysis of endonuclease R-EcoRI fragments of DNA from lambdoid bacteriophages and other viruses by agarose-gel electrophoresis. J Virol (1974) 23.54
Replication and transcription of eukaryotic DNA in Escherichia coli. Proc Natl Acad Sci U S A (1974) 10.51
Comprehensive geriatric assessment: a meta-analysis of controlled trials. Lancet (1993) 8.39
The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells. Cancer Res (2001) 6.93
Inhibition of HIV-1 replication by a nonnucleoside reverse transcriptase inhibitor. Science (1990) 5.49
Benefit of cervical screening at different ages: evidence from the UK audit of screening histories. Br J Cancer (2003) 4.14
Estimation of the number of sex alleles and queen matings from diploid male frequencies in a population of Apis mellifera. Genetics (1977) 3.98
The learning curve for laparoscopic colorectal surgery. Preliminary results from a prospective analysis of 1194 laparoscopic-assisted colectomies. Arch Surg (1997) 3.57
Effect of screening on cervical cancer mortality in England and Wales: analysis of trends with an age period cohort model. BMJ (1999) 3.50
A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma. Br J Haematol (2004) 3.49
NG-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide. Proc Natl Acad Sci U S A (1990) 3.28
Eya1-deficient mice lack ears and kidneys and show abnormal apoptosis of organ primordia. Nat Genet (1999) 3.24
Microbial evolution in a simple unstructured environment: genetic differentiation in Escherichia coli. Genetics (1994) 3.19
Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br Med J (Clin Res Ed) (1986) 3.14
Coronary vasospasm induced by subcutaneous sumatriptan. BMJ (1992) 3.13
RNA recognition by a Staufen double-stranded RNA-binding domain. EMBO J (2000) 3.12
Frequency of fixation of adaptive mutations is higher in evolving diploid than haploid yeast populations. Nature (1983) 3.03
Reversal of endotoxin-mediated shock by NG-methyl-L-arginine, an inhibitor of nitric oxide synthesis. Biochem Biophys Res Commun (1990) 2.77
Repeated evolution of an acetate-crossfeeding polymorphism in long-term populations of Escherichia coli. Mol Biol Evol (1998) 2.69
Novel proteasome inhibitor PS-341 inhibits activation of nuclear factor-kappa B, cell survival, tumor growth, and angiogenesis in squamous cell carcinoma. Clin Cancer Res (2001) 2.65
Polycystic ovaries--a common finding in normal women. Lancet (1988) 2.58
A novel dipyridodiazepinone inhibitor of HIV-1 reverse transcriptase acts through a nonsubstrate binding site. Biochemistry (1991) 2.57
Pattern of malformations in the children of women treated with carbamazepine during pregnancy. N Engl J Med (1989) 2.56
Evidence for high-energy extraterrestrial neutrinos at the IceCube detector. Science (2013) 2.56
Determinants of patient satisfaction and willingness to return with emergency care. Ann Emerg Med (2000) 2.49
Admixture studies and the detection of selection. Science (1973) 2.41
Relative fitness can decrease in evolving asexual populations of S. cerevisiae. Nature (2006) 2.40
Arm edema in breast cancer patients. J Natl Cancer Inst (2001) 2.35
A systematic review of the role of human papillomavirus testing within a cervical screening programme. Health Technol Assess (1999) 2.32
Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome. BMJ (1988) 2.29
Intermittent versus continuous renal replacement therapy for acute renal failure in adults. Cochrane Database Syst Rev (2007) 2.26
Enhanced chemosensitivity to CPT-11 with proteasome inhibitor PS-341: implications for systemic nuclear factor-kappaB inhibition. Cancer Res (2001) 2.18
Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone. Lancet (1986) 2.14
Case-mix adjustment of the National CAHPS benchmarking data 1.0: a violation of model assumptions? Health Serv Res (2001) 2.10
Screening for vertebral osteoporosis using individual risk factors. The Multicentre Vertebral Fracture Study Group. Osteoporos Int (1991) 2.07
Fas ligand, Bcl-2, granulocyte colony-stimulating factor, and p38 mitogen-activated protein kinase: Regulators of distinct cell death and survival pathways in granulocytes. J Exp Med (2000) 2.07
Frequency-Dependent Selection for Plasmid-Containing Cells of ESCHERICHIA COLI. Genetics (1979) 2.07
Changing rates of adenocarcinoma and adenosquamous carcinoma of the cervix in England. Lancet (2001) 2.05
Proteasome inhibition measurements: clinical application. Clin Chem (2000) 2.04
Ovulatory disorders in women with polycystic ovary syndrome. Clin Obstet Gynaecol (1985) 2.00
First observation of PeV-energy neutrinos with IceCube. Phys Rev Lett (2013) 2.00
Estimation of phylogenetic relationships from DNA restriction patterns and selection of endonuclease cleavage sites. Proc Natl Acad Sci U S A (1982) 1.98
Genetic evidence that Neisseria gonorrhoeae produces specific receptors for transferrin and lactoferrin. J Bacteriol (1990) 1.94
The proteasome inhibitor PS-341 in cancer therapy. Clin Cancer Res (1999) 1.94
Characterization of the binding site for nevirapine (BI-RG-587), a nonnucleoside inhibitor of human immunodeficiency virus type-1 reverse transcriptase. J Biol Chem (1991) 1.90
Distinct roles of two conserved Staufen domains in oskar mRNA localization and translation. EMBO J (2000) 1.87
The maintenance of Plasmid-containing organisms in populations of Escherichia coli. J Gen Microbiol (1981) 1.85
Laparoscopic complications in markedly obese urologic patients (a multi-institutional review) Urology (1996) 1.75
The effect of arabinose-specific enzyme synthesis on recombination in the arabinose genes of Escherichia coli. Genetics (1967) 1.72
Role of the proteasome and NF-kappaB in streptococcal cell wall-induced polyarthritis. Proc Natl Acad Sci U S A (1998) 1.69
Enhancement of radiosensitivity by proteasome inhibition: implications for a role of NF-kappaB. Int J Radiat Oncol Biol Phys (2001) 1.67
Continuous ambulatory peritoneal dialysis versus automated peritoneal dialysis for end-stage renal disease. Cochrane Database Syst Rev (2007) 1.67
Selection for citrate synthase deficiency in icd mutants of Escherichia coli. J Bacteriol (1976) 1.67
Fibromyalgia: a risk factor for osteoporosis. J Rheumatol (1999) 1.63
Nonoperative management of posterior tibial tendon dysfunction. Foot Ankle Int (1996) 1.61
Evaluation of outpatient geriatric assessment: a randomized multi-site trial. J Am Geriatr Soc (1995) 1.58
Molecular and imaging correlates of the fragile X-associated tremor/ataxia syndrome. Neurology (2006) 1.55
Cysteine usage increases the need for acetate in neonates who receive total parenteral nutrition. Am J Clin Nutr (1991) 1.53
Proteasome inhibition with bortezomib (PS-341): a phase I study with pharmacodynamic end points using a day 1 and day 4 schedule in a 14-day cycle. J Clin Oncol (2005) 1.50
Pharmacological effects of SB 220025, a selective inhibitor of P38 mitogen-activated protein kinase, in angiogenesis and chronic inflammatory disease models. J Pharmacol Exp Ther (1998) 1.46
A community-level HIV prevention intervention for inner-city women: results of the women and infants demonstration projects. Am J Public Health (2000) 1.46
Ultrasound demonstration of increased frequency of functional ovarian cysts in women using progestogen-only oral contraception. Br J Obstet Gynaecol (1985) 1.44
Characterizing discrete subsets of polycystic ovary syndrome as defined by the Rotterdam criteria: the impact of weight on phenotype and metabolic features. J Clin Endocrinol Metab (2006) 1.41
Juvenile spring eruption of the ears: a probable variant of polymorphic light eruption. Br J Dermatol (1991) 1.40
Wnt pathway regulation in chronic renal allograft damage. Am J Transplant (2009) 1.39
The Wake-up Call. West J Med (1993) 1.39
ATP-induced killing of virulent Mycobacterium tuberculosis within human macrophages requires phospholipase D. J Immunol (2000) 1.38
Orientation of histopathology specimens. Br J Oral Maxillofac Surg (2004) 1.38
Defining constant versus variable phenotypic features of women with polycystic ovary syndrome using different ethnic groups and populations. J Clin Endocrinol Metab (2006) 1.38
Event-related potentials in schizophrenia: their biological and clinical correlates and a new model of schizophrenic pathophysiology. Schizophr Res (1991) 1.38
The use of traditional, complementary and alternative medicine in Sri Lankan cancer care: results from a survey of 500 cancer patients. Public Health (2010) 1.36
Identification of vertebral fractures: an update. Osteoporos Int (2005) 1.34
Fitness effects of Ty transposition in Saccharomyces cerevisiae. Genetics (1992) 1.33
Estimation of expected number of rare alleles of a locus and calculation of mutation rate. Proc Natl Acad Sci U S A (1978) 1.32
Nalidixic acd-resistant mutants of Escherichia coli deficient in isocitrate dehydrogenase. J Bacteriol (1971) 1.32
Too much of a good thing: retinoic acid as an endogenous regulator of neural differentiation and exogenous teratogen. Eur J Neurosci (2003) 1.32
The relationship between enzyme activity, cell geometry, and fitness in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (1975) 1.31
Detection of Epstein-Barr virus genomes in Hodgkin's disease: relation to age. J Clin Pathol (1991) 1.29
Population studies in microorganisms. I. Evolution of diploidy in Saccharomyces cerevisiae. Genetics (1974) 1.28
Physiological characterization of adaptive clones in evolving populations of the yeast, Saccharomyces cerevisiae. Genetics (1985) 1.28
Association between amputation, arthritis and osteopenia in British male war veterans with major lower limb amputations. Clin Rehabil (1998) 1.28
Induction of ovulation with pulsatile luteinising hormone releasing hormone. Br Med J (Clin Res Ed) (1984) 1.26
Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by the dipyridodiazepinone BI-RG-587. J Infect Dis (1991) 1.26
Structure of evolving populations of Saccharomyces cerevisiae: adaptive changes are frequently associated with sequence alterations involving mobile elements belonging to the Ty family. Proc Natl Acad Sci U S A (1986) 1.26
Tetracycline-resistant gonococci in UK. Lancet (1988) 1.26
The response of general practitioners to the threat of violence in their practices: results from a qualitative study. Fam Pract (2006) 1.25
Mechanisms of immune lysis of the red cells in hereditary erythroblastic multinuclearity with a positive acidified serum test and paroxysmal nocturnal hemoglobinuria. J Clin Invest (1974) 1.24
Lack of multicellular drug resistance observed in human ovarian and prostate carcinoma treated with the proteasome inhibitor PS-341. Clin Cancer Res (2000) 1.24
Nalidixic acid-resistant auxotrophs of Escherichia coli. J Bacteriol (1970) 1.24
New insights into proteasome function: from archaebacteria to drug development. Chem Biol (1995) 1.23
26S proteasome inhibition induces apoptosis and limits growth of human pancreatic cancer. J Cell Biochem (2001) 1.23
The population biology and evolutionary significance of Ty elements in Saccharomyces cerevisiae. Genetica (1992) 1.23
Role of nitric oxide in lysis of tumor cells by cytokine-activated endothelial cells. Cancer Res (1991) 1.22
Bone marrow lesions predict increase in knee cartilage defects and loss of cartilage volume in middle-aged women without knee pain over 2 years. Ann Rheum Dis (2008) 1.22
1,25-Dihydroxyvitamin D inhibits lipopolysaccharide-induced immune activation in human endothelial cells. Clin Exp Immunol (2006) 1.22
Standardized lifetime risk. Am J Epidemiol (1999) 1.21
Predicting patient visits to an urgent care clinic using calendar variables. Acad Emerg Med (2001) 1.21